Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Welch Allyn Protocol's wireless patient monitor:

This article was originally published in Clinica

Executive Summary

Welch Allyn Protocol has received US FDA 510(k) clearance to market its Micropaq wireless ambulatory patient monitor. The device, developed principally for cardiac care, monitors ECG, heart rate and pulse oximetry. It is compact and wearable, weighing under a pound. The product can be connected wirelessly to the Beaverton, Oregon company's Acuity central workstation and its FlexNet network, which provide vital signs data and patient information between any locations via secure internet access. The device can also be used in applications outside cardiac care because it provides an LCD of vital sign data and can operate outside of the wireless network.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069503

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel